Dr. Claudio Orlich is the director of CLINICA 20/20. He studied medicine in Costa Rica and completed his residency in Ophthalmology at the Dr. Luis Sánchez Bulnes Hospital of the Association to Prevent Blindness in Mexico (APEC). At the end of the residency, he studied a subspecialty in Cornea and Refractive Surgery, in the Cornea Service of the APEC.

Dr. Orlich is a member of the Costa Rican Association of Ophthalmology, the American Academy of Ophthalmology (AAO), the American Association of Cataract and Refractive Surgeons (ASCRS). He is also, a honorary member of the Colombian Ophthalmology Society, among other important medical associations.

From March 2003 to September 2008, he worked at the National Children's Hospital and the Ophthalmology Clinic of the Costa Rican Social Security Fund.

During 2005, he performed the first implants of "Anillos de Ferrara" in Costa Rica, helped and trained by Dr. Paulo Ferrara, a Brazilian ophthalmologist who invented and developed these implants. In 2007, he performed the first artificial cornea transplant (Alphacor) in the country, which made him the first ophthalmologist in Latin America to apply this type of procedure.

Two years later, he introduced the first Intralase in Central America and the Caribbean, precisely in Costa Rica. This allowed him to develop the first laser cornea transplant surgeries and the "intrastromal rings" implants, also 100% laser, we currently have state-of-the-art equipment and technologies.

In 2011, Dr. Orlich was the first Central American doctor to perform laser cataract surgeries, using the LenSx, the first femtosecond laser approved by the FDA.

Dr. Orlich has published articles in medical journals and has collaborated in the writing of ophthalmology books. Likewise, he has been a special guest professor at numerous international ophthalmology conferences.